Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors

Richard J. Hammond, Benjamin W. Poston, Brent D. Feske

Research output: Contribution to conference › Presentation

Fingerprint

Dive into the research topics of 'Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Chemistry

Material Science